Search Page

1

Cite

Share

Recent advances in the understanding and management of hepatorenal syndrome.

Simbrunner B, Trauner M, Reiberger T, Mandorfer M. Simbrunner B, et al. Fac Rev. 2021 May 21;10:48. doi: 10.12703/r/10-48. eCollection 2021. Fac Rev. 2021. PMID: 34131658 Free PMC article. Review.

Cite

Share

2

Cite

Share

Prevention of First Decompensation in Advanced Chronic Liver Disease.

Mandorfer M, Simbrunner B. Mandorfer M, et al. Among authors: simbrunner b. Clin Liver Dis. 2021 May;25(2):291-310. doi: 10.1016/j.cld.2021.01.003. Epub 2021 Mar 10. Clin Liver Dis. 2021. PMID: 33838851 Free article. Review.

Cite

Share

3

Cite

Share

Gut-liver axis signaling in portal hypertension.

Simbrunner B, Mandorfer M, Trauner M, Reiberger T. Simbrunner B, et al. World J Gastroenterol. 2019 Oct 21;25(39):5897-5917. doi: 10.3748/wjg.v25.i39.5897. World J Gastroenterol. 2019. PMID: 31660028 Free PMC article. Review.

Cite

Share

4

Cite

Share

Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.

Hartl L, Jachs M, Simbrunner B, Bauer DJM, Semmler G, Gompelmann D, Szekeres T, Quehenberger P, Trauner M, Mandorfer M, Scheiner B, Reiberger T. Hartl L, et al. Among authors: simbrunner b. J Pers Med. 2021 Dec 1;11(12):1264. doi: 10.3390/jpm11121264. J Pers Med. 2021. PMID: 34945736 Free PMC article.

Cite

Share

5

Cite

Share

Recent outbreaks of severe hepatitis A virus infections in Vienna.

Bauer D, Farthofer A, Chromy D, Simbrunner B, Steininger L, Schmidbauer C, Binter T, Trauner M, Mandorfer M, Schmidt R, Mayer F, Holzmann H, Strassl R, Reiberger T. Bauer D, et al. Among authors: simbrunner b. Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):335-344. doi: 10.1007/s10096-020-04028-x. Epub 2020 Sep 17. Eur J Clin Microbiol Infect Dis. 2021. PMID: 32940811 Free PMC article.

Cite

Share

6

Cite

Share

Review article: therapeutic aspects of bile acid signalling in the gut-liver axis.

Simbrunner B, Trauner M, Reiberger T. Simbrunner B, et al. Aliment Pharmacol Ther. 2021 Nov;54(10):1243-1262. doi: 10.1111/apt.16602. Epub 2021 Sep 23. Aliment Pharmacol Ther. 2021. PMID: 34555862 Review.

Cite

Share

7

Cite

Share

Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.

Schmidbauer C, Chromy D, Schmidbauer VU, Schwarz M, Jachs M, Bauer DJM, Binter T, Apata M, Nguyen DT, Mandorfer M, Simbrunner B, Rieger A, Mayer F, Breuer M, Strassl R, Schmidt R, Holzmann H, Trauner M, Gschwantler M, Reiberger T. Schmidbauer C, et al. Among authors: simbrunner b. Liver Int. 2021 Nov;41(11):2622-2634. doi: 10.1111/liv.15018. Epub 2021 Aug 5. Liver Int. 2021. PMID: 34268869

Cite

Share

8

Cite

Share

Outcomes of an HCV elimination program targeting the Viennese MSM population.

Jachs M, Binter T, Chromy D, Schalk H, Pichler K, Bauer D, Simbrunner B, Hartl L, Schmidbauer C, Mayer F, Strassl R, Mandorfer M, Gschwantler M, Reiberger T. Jachs M, et al. Among authors: simbrunner b. Wien Klin Wochenschr. 2021 Jul;133(13-14):635-640. doi: 10.1007/s00508-021-01898-9. Epub 2021 Jun 28. Wien Klin Wochenschr. 2021. PMID: 34181068 Free PMC article.

Cite

Share

9

Cite

Share

Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease".

Costa D, Simbrunner B, Reiberger T. Costa D, et al. Among authors: simbrunner b. J Hepatol. 2021 Apr;74(4):1000-1001. doi: 10.1016/j.jhep.2021.01.026. Epub 2021 Jan 23. J Hepatol. 2021. PMID: 33497763 No abstract available.

Cite

Share

10

Cite

Share

Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease".

Simbrunner B, Costa D, Reiberger T. Simbrunner B, et al. J Hepatol. 2021 Jul;75(1):234-236. doi: 10.1016/j.jhep.2021.03.027. Epub 2021 Apr 20. J Hepatol. 2021. PMID: 33852949 No abstract available.

Cite

Share